Buyer's Guide

Contact | Print version | PDF version | Recommend company

Portrait
The Bristol-Myers Squibb Research and Development (R&D) organization is one of the world's most innovative, productive, and respected scientific research organizations. Our purpose is: to discover and develop innovative, cost-effective medicines that address significant unmet medical needs and enhance and extend human life. Moreover, R&D is an extraordinary area in which to work—thanks to 7,000 employees’ remarkable talent, dedication, and passion for using science to improve human health.

In less than four years, R&D has delivered eight new drugs. By industry standards, this places Bristol-Myers Squibb among the most productive pharmaceutical companies in the world today. New products include treatments for several major disease areas, including cancer, psychiatric disorders, HIV/AIDS, hepatitis B, and rheumatoid arthritis.

In addition, our research and development activities—centered in four major U.S. facilities and numerous other facilities in the U.S. and worldwide—are creating and sustaining an outstanding pipeline. Compounds with exciting potential are progressing through discovery, exploratory development, and full development expeditiously. With an intense focus on areas of significant unmet medical need, we are working to discover and develop treatments specifically for:

* cancer
* atherosclerosis/thrombosis
* diabetes
* obesity
* psychiatric disorders
* Alzheimer’s disease
* hepatitis
* HIV/AIDS
* rheumatoid arthritis
* and solid organ transplant rejection.

Industrial Sectors

Pharmacy